Patents by Inventor Gerald Siu

Gerald Siu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTHRAQUINONE-BASED COVALENT ORGANIC FRAMEWORKS
    Publication number: 20240140969
    Abstract: Anthraquinone-based covalent organic frameworks; methods for preparing anthraquinone-based covalent organic frameworks; solid electrolyte interphases including the anthraquinone-based covalent organic frameworks; and electrochemical devices including the solid electrolyte interphases. The solid electrolyte interphases can exhibit enhanced transport of Li+. Battery cells including the solid electrolyte interphase exhibit improved reversible capacities.
    Type: Application
    Filed: October 12, 2023
    Publication date: May 2, 2024
    Inventors: Yoonseob KIM, Chen LI, Gerald Siu Hang POON HO, Jun HUANG, Gitaek BANG
  • Human anti-B7RP1 neutralizing antibodies
    Patent number: 10072090
    Abstract: This invention provides antibodies that interact with or bind to human B7 related protein-1 (B7RP1) and antibodies that bind to and neutralize the function of B7RP1 thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing B7RP1 function, and particularly for treating immune disorders (e.g., inappropriate immune response) by administering a pharmaceutically effective amount of anti-B7RP1 antibodies. Methods of detecting the amount of B7RP1 in a sample using anti-B7RP1 antibodies are also provided.
    Type: Grant
    Filed: January 14, 2016
    Date of Patent: September 11, 2018
    Assignees: AMGEN INC., MEDAREX INC.
    Inventors: Gerald Siu, Wenyan Shen, Steven K. Yoshinaga, Haichun Huang
  • Human Anti-B7RP1 Neutralizing Antibodies
    Publication number: 20160145345
    Abstract: This invention provides antibodies that interact with or bind to human B7 related protein-1 (B7RP1) and antibodies that bind to and neutralize the function of B7RP1 thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing B7RP1 function, and particularly for treating immune disorders (e.g., inappropriate immune response) by administering a pharmaceutically effective amount of anti-B7RP1 antibodies. Methods of detecting the amount of B7RP1 in a sample using anti-B7RP1 antibodies are also provided.
    Type: Application
    Filed: January 14, 2016
    Publication date: May 26, 2016
    Inventors: Gerald Siu, Wenyan Shen, Steven K. Yoshinaga, Haichun Huang
  • Human anti-B7RP1 neutralizing antibodies
    Patent number: 9266945
    Abstract: This invention provides antibodies that interact with or bind to human B7 related protein-1 (B7RP1) and antibodies that bind to and neutralize the function of B7RP1 thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing B7RP1 function, and particularly for treating immune disorders (e.g., inappropriate immune response) by administering a pharmaceutically effective amount of anti-B7RP1 antibodies. Methods of detecting the amount of B7RP1 in a sample using anti-B7RP1 antibodies are also provided.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: February 23, 2016
    Assignees: AMGEN INC., E.R. SQUIBB & SONS, L.L.C.
    Inventors: Gerald Siu, Wenyan Shen, Steven K. Yoshinaga, Haichun Huang
  • Human anti-B7RP1 neutralizing antibodies
    Patent number: 8981071
    Abstract: This invention provides antibodies that interact with or bind to human B7 related protein-1 (B7RP1) and antibodies that bind to and neutralize the function of B7RP1 thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing B7RP1 function, and particularly for treating immune disorders (e.g., inappropriate immune response) by administering a pharmaceutically effective amount of anti-B7RP1 antibodies. Methods of detecting the amount of B7RP1 in a sample using anti-B7RP1 antibodies are also provided.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: March 17, 2015
    Assignees: Amgen, Inc., Medarex, L.L.C.
    Inventors: Gerald Siu, Wenyan Shen, Steven K. Yoshinaga, Haichun Huang
  • Human anti-B7RP1 Neutralizing Antibodies
    Publication number: 20110104757
    Abstract: This invention provides antibodies that interact with or bind to human B7 related protein-1 (B7RP1) and antibodies that bind to and neutralize the function of B7RP1 thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing B7RP1 function, and particularly for treating immune disorders (e.g., inappropriate immune response) by administering a pharmaceutically effective amount of anti-B7RP1 antibodies. Methods of detecting the amount of B7RP1 in a sample using anti-B7RP1 antibodies are also provided.
    Type: Application
    Filed: December 22, 2010
    Publication date: May 5, 2011
    Applicant: Amgen Inc.
    Inventors: Gerald Siu, Wenyan Shen, Steven Kiyoshi Yoshinaga, Haichun Huang
  • Human anti-B7RP1 neutralizing antibodies
    Patent number: 7868140
    Abstract: This invention provides antibodies that interact with or bind to human B7 related protein-1 (B7RP1) and antibodies that bind to and neutralize the function of B7RP1 thereby. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing B7RP1 function, and particularly for treating immune disorders (e.g., inappropriate immune response) by administering a pharmaceutically effective amount of anti-B7RP1 antibodies. Methods of detecting the amount of B7RP1 in a sample using anti-B7RP1 antibodies are also provided.
    Type: Grant
    Filed: July 18, 2006
    Date of Patent: January 11, 2011
    Assignees: Amgen Inc., Medarex Inc.
    Inventors: Gerald Siu, Wenyan Shen, Steven Kiyoshi Yoshinaga, Haichun Huang
  • Human anti-B7RP1 Neutralizing Antibodies
    Publication number: 20080166352
    Abstract: This invention provides antibodies that interact with or bind to human B7 related protein-1 (B7RP1) and antibodies that bind to and neutralize the function of B7RP1 thereby The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing B7RP1 function, and particularly for treating immune disorders (e.g., inappropriate immune response) by administering a pharmaceutically effective amount of anti-B7RP1 antibodies Methods of detecting the amount of B7RP1 in a sample using anti-B7RP1 antibodies are also provided.
    Type: Application
    Filed: July 18, 2006
    Publication date: July 10, 2008
    Applicant: AMGEN INC.
    Inventors: Gerald Siu, Wenyan Shen, Steven Kiyoshi Yoshinaga, Haichun Huang